the company develops and manufactures medical devices that enable the therapeutic use of the adult stem and regenerative cells naturally found within adipose fat tissue commercial activities are focused on cosmetic reconstructive surgery cell banking and supplying research tools cytori therapeutics inc is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions the company was created as the result of a 2002 merger between macropore biosurgery inc founded in 1996 and stemsource inc founded in 2000 the joint company operated under the macropore name until 2005 when it changed its name to cytori therapeutics cytori is headquartered in san diego ca and also has operations in japan and the united kingdom cytori develops cellular therapeutics formulated for specific diseases and medical conditions clinical development programs are currently targeting impaired hand function in scleroderma phase iii clinical osteoarthritis of the knee phase ii clinical and thermal burn injury preclinical phase cytori s cellular therapeutics are collectively known as cytori cell therapytm and consist of different formulations of a heterogeneous population of cells including stem cells that are involved in response to injury repair and healing this cell therapy product is